BIOMAT Database Logo BIOMAT Database Logo

T and tumour antigens of adenovirus group C-infected and transformed cells. 1968

R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009858 Oncogenic Viruses Viruses that produce tumors. Tumor Viruses,Oncogenic Virus,Tumor Virus,Virus, Oncogenic,Virus, Tumor,Viruses, Oncogenic,Viruses, Tumor
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
The group C adenovirus tumor antigens: identification in infected and transformed cells and a peptide map analysis.
August 1977, Cell,
R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
Characterization of T antigens in polyoma-infected and transformed cells.
September 1978, Cell,
R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
Two tumor antigens and their polypeptides in adenovirus type 12-infected and transformed cells.
April 1980, Proceedings of the National Academy of Sciences of the United States of America,
R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
T antigens of SV40-transformed cells.
January 1980, Cold Spring Harbor symposia on quantitative biology,
R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
Immunofluorescence of simian adenovirus 7 (SA7)--specific antigens in infected LLC-MK 2 cells and SA7 transformed cells.
February 1973, Experimental and molecular pathology,
R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
Phosphorylation patterns of tumour antigens in cells lytically infected or transformed by simian virus 40.
October 1981, Journal of virology,
R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
Recent studies on the characteristics of adenovirus-infected and -transformed cells.
January 1975, Cold Spring Harbor symposia on quantitative biology,
R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
Immunofluorescence of adenovirus type 7 T-antigen(s) and virion antigens in infected KB cells.
July 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
Identification of adenovirus 12-encoded E1A tumor antigens synthesized in infected and transformed mammalian cells and in Escherichia coli.
October 1984, Journal of virology,
R V Gilden, and J Kern, and A E Freeman, and C E Martin, and R C McAllister, and H C Turner, and R J Huebner
Immunoprecipitation of protein kinase activity from adenovirus 5-infected cells using antiserum directed against tumour antigens.
January 1979, Nature,
Copied contents to your clipboard!